UPDATE 1-U.S. FTC sues Endo alleging antitrust violations

March 31 (Reuters) - The U.S. Federal Trade Commission said it filed a complaint in a district court accusing Endo International Plc of violating antitrust laws by striking "pay-for-delay" deals to block access to generic copies of its drugs.